ALK5

Researchers report in Nature that the enzyme UCHL5 stabilizes the receptor ALK5, driving an autophagy-dependent ferroptosis process in cartilage cells in osteoarthritis. The findings point to a previously underappreciated mechanism in joint degeneration and suggest UCHL5 or the ALK5 pathway as potential targets for future osteoarthritis treatments, a disease with few options beyond symptom management.